Physician profile
Peter Can Wickwire
NPI 1427410851
$1,026.47
in general payments reported to CMS, 2019-2025
17 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $306 · 2023: $259 · 2024: $155 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $178.04 | 2022-2024 | Rhino-Laryngo Videoscope |
| Depuy Synthes Sales INC. | $152.75 | 2022-2025 | Trumatch |
| Inspire Medical Systems, INC. | $116.50 | 2023-2024 | Inspire |
| Stryker Corporation | $89.80 | 2021 | |
| Ethicon US, LLC | $77.78 | 2023 | Stratafix, Vistaseal, Dermabond |
| Smith+Nephew, INC. | $74.00 | 2021 | |
| Polynovo North America LLC | $60.62 | 2023-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $45.02 | 2023 | Cusa Clarity, Duraseal Exact Spinal Sealant System, Codman Certas |
| Brainlab, INC. | $35.13 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Genzyme Corporation | $30.63 | 2022 | |
| Axogen | $29.23 | 2025 | |
| Acera Surgical, INC. | $27.90 | 2023 | Restrata Wound Matrix |
| Davol INC. | $26.45 | 2025 | Phasix Mesh |
| Preceptis Medical, INC. | $25.65 | 2023 | Hummingbird Tympanostomy Tube System |
| Acclarent, INC | $23.02 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $17.45 | 2022 | |
| Mimedx Group, INC. | $16.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wickwire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.